Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Holick

Showing results (121-130 of 246) with videos related to

Pageof 25
Sort By:
Journal of the American Academy of Dermatology|September 1, 1988
A novel approach for the evaluation and treatment of psoriasis. Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasisE L Smith, S H Pincus, L Donovan, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1995
Compensation for the interracial variance in the cutaneous synthesis of vitamin DL Y Matsuoka, J Wortsman, T C Chen, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 12, 2004
Oncogenic osteomalacia: clinical presentation, densitometric findings, and response to therapyA O Malabanan, A K Turner, I N Rosenberg, et al.
Metabolism: Clinical and Experimental|December 11, 1975
Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidismR M Neer, M F Holick, H F DeLuca, et al.
The American Journal of Physiology|August 1, 1986
Effects of serum calcium and phosphorus on skeletal mineralization in vitamin D-deficient ratsM E Holtrop, K A Cox, D L Carnes, et al.
The Journal of Clinical Investigation|March 1, 1974
The acute effect of 25-hydroxycholecalciferol on renal handling of phosphorus. Evidence for a parathyroid hormone-dependent mechanismM M Popovtzer, J B Robinette, H F DeLuca, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1985
Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3J A MacLaughlin, W Gange, D Taylor, et al.
Lancet (London, England)|January 9, 1982
Increased skin pigment reduces the capacity of skin to synthesise vitamin D3T L Clemens, J S Adams, S L Henderson, et al.
JAMA|October 6, 1975
1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferolJ C Chan, S B Oldham, M F Holick, et al.
Lancet (London, England)|August 11, 1973
X-linked hypophosphataemic rickets: Inadequate therapeutic response to 1,25-dihydroxycholecalciferolF H Glorieux, M F Holick, C R Scriver, et al.
Pageof 25

Showing results (121-130 of 246) with videos related to

Sort By:
Pageof 25
Journal of the American Academy of Dermatology|September 1, 1988
A novel approach for the evaluation and treatment of psoriasis. Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasisE L Smith, S H Pincus, L Donovan, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1995
Compensation for the interracial variance in the cutaneous synthesis of vitamin DL Y Matsuoka, J Wortsman, T C Chen, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 12, 2004
Oncogenic osteomalacia: clinical presentation, densitometric findings, and response to therapyA O Malabanan, A K Turner, I N Rosenberg, et al.
Metabolism: Clinical and Experimental|December 11, 1975
Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidismR M Neer, M F Holick, H F DeLuca, et al.
The American Journal of Physiology|August 1, 1986
Effects of serum calcium and phosphorus on skeletal mineralization in vitamin D-deficient ratsM E Holtrop, K A Cox, D L Carnes, et al.
The Journal of Clinical Investigation|March 1, 1974
The acute effect of 25-hydroxycholecalciferol on renal handling of phosphorus. Evidence for a parathyroid hormone-dependent mechanismM M Popovtzer, J B Robinette, H F DeLuca, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1985
Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3J A MacLaughlin, W Gange, D Taylor, et al.
Lancet (London, England)|January 9, 1982
Increased skin pigment reduces the capacity of skin to synthesise vitamin D3T L Clemens, J S Adams, S L Henderson, et al.
JAMA|October 6, 1975
1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferolJ C Chan, S B Oldham, M F Holick, et al.
Lancet (London, England)|August 11, 1973
X-linked hypophosphataemic rickets: Inadequate therapeutic response to 1,25-dihydroxycholecalciferolF H Glorieux, M F Holick, C R Scriver, et al.
Pageof 25